Log In
Print this Print this

Systebryl (PTI-110)

  Manage Alerts
Collapse Summary General Information
Company ProteoTech Inc.
DescriptionSmall molecule that reduces amyloid fibril deposits of the Ig light chain, transthyretin (TTR) and AA amyloid types
Molecular Target Amyloid ; Transthyretin (TTR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyloidosis
Indication DetailsTreat amyloid light-chain (AL) amyloidosis; Treat transthyretin (TTR) amyloidosis
Regulatory Designation U.S. - Orphan Drug (Treat amyloid light-chain (AL) amyloidosis)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today